Thrive Acquisition, which registered less than three weeks ago to raise $200 million, in an amended S-1 filing said it will now offer 15 million units to raise $150 million in an IPO.
A unit will still consist of one Class A ordinary share and one-half of a warrant.
The SPAC’s focus remains on the global health and wellness industry.
Thrive is led by Director and CEO Charles Jobson, the founder of Delta Partners, a global equity hedge fund.
BTIG is lone book-running manager for the offering. The underwriters have the option to purchase up to 2.25 million additional units to cover any over-allotments.
Thrive inteds to apply for a Nasdaq listing under the symbol THAC.U. Read more.
